Propel

Propel is providing entrepreneurs with access to specialized resources and expertise to prepare them for early-stage funding.

Business Model:

Revenue: $0

Employees: 0-0

Rankings

Detailed Propel Information

Geographic Data

Propel headquarters map

Address: Suite 400

City: Chicago

State: IL

Zip: 60607

Country: US

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$0

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Started in 2007, PROPEL helps guide the development of formation-stage and early-stage life sciences companies by providing entrepreneurs with access to specialized resources and expertise to prepare them for early-stage funding. PROPEL has awarded &g;$1.2 million in grants and awards since 2007. This has had a strong leverage effect: for each $1 awarded, PROPEL portfolio companies raised $214 in new funding. Industry initially led the development of PROPEL through generous support from Abbott and AbbVie, Astellas Pharma US, Inc., Baxter International Inc. and Takeda Pharmaceuticals North America. Today, PROPEL has strong support from the broad life sciences community encompassing the three pillars of financial support: corporate/industry; private foundations; and public/government. In the last several years, funding sources include: iBIO, corporate partners (listed above), grants from the Searle Funds of The Chicago Community Trust, US Small Business Administration, the City of Chicago and Illinois DCEO.

Contact Phone:
+13124221111

Contact Email:

Announced Date Company Transaction Money Raised
4/2022 Newfront Series D 0
4/2016 NovaScan Grant 0
5/2022 Nomad Series B 0
5/2022 Nomad Series B 0
4/2022 Newfront Series D 0
4/2016 NovaScan Grant 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research